Elizabeth Mily
Vermögen: 675 225 $ am 31.05.2026
Vermögen: 675 225 $ am 31.05.2026
Elizabeth Mily ist Executive VP-Strategy & Business Development bei Bristol Myers Squibb Co. In der Vergangenheit hatte Frau Mily die Position des Head-Corporate Strategy & Development bei Thermo Fisher Scientific, Inc. inne, war Managing Director bei Goldman Sachs & Co. LLC und Senior Member-Global Healthcare Group bei Barclays US LLC. Sie erwarb einen Abschluss an der Georgetown University und einen Bachelor-Abschluss an der Ohio State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,01 % | 15.05.2026 | 9 009 ( 0,01 % ) | 675 225 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Vorstandsvorsitzender | 08.01.2024 |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Vorstandsvorsitzender | 01.06.2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2024 |
| BARCLAYS PLC | Corporate Officer/Principal | 01.01.2020 |
| C.R. BARD | Präsident | 01.01.2017 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01.01.2010 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 14 |
|---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Barclays PLC
Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Barclays US LLC
Barclays US LLC Regional BanksFinance Operates as a bank holding company whose subsidiaries provides banking services | Finance |
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Finance |
Stephen Gaynor School
Stephen Gaynor School Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit pre-K school | Commercial Services |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen